CureVac Swiss AG submits application for authorisation of COVID-19 vaccine (CVnCoV) to Swissmedic
Bern, 19.4.2021 - Another COVID-19 vaccine under rolling review: CureVac Swiss AG has submitted an application for the authorisation of its COVID-19 vaccine candidate CVnCoV to Swissmedic. This is the fifth authorisation procedure initiated in Switzerland for a vaccine against the SARS-CoV-2 virus.